A breakthrough combination of new silicone materials and advanced 3D printing technology developed by University of Waterloo researchers could transform how contact lenses are manufactured.
Disease progression in people with Parkinson’s disease can be accurately monitored using sensors, removing some of the limitations of wearable technologies, a new study reports.
Scientists can use patient-derived tissue samples to grow miniature versions of human organs, allowing them to test new medications and disease treatments for personalized care.
STOCKHOLM, July 13, 2026 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the US Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once weekly lecanemab irmb subcutaneous injection (US brand name: Leqembi Iqlik®) as a starting dose for the treatment of early Alzheimer’s disease. The US launch is planned for late August 2026.
To develop new and better peptides, the short amino acid strings behind medicines like GLP-1 drugs, researchers have used AI to generate candidates and to predict their properties.
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative.
Good sleep is essential for brain health. During sleep and rest, the glymphatic system, the brain’s waste-clearing process, helps remove metabolic waste that accumulates during waking hours.
Thread-based electronics that conform to the body could point toward softer, less obtrusive health monitors
A high-performance biodegradable pressure sensor has been developed as a key technology for wearable AI health care robotics and user-friendly robotic systems.
Fertility declines as women get older for many reasons, such as a drop in egg quality, decreased follicle numbers and hardening of ovarian tissues.